New Glioma clinical trials: 176 posted since Nov 2024

Name: New Glioma clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Glioma clinical trials: 176 rows for $8.80, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 6 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/glioma, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 2, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

176 clinical studies in glioma were first posted on ClinicalTrials.gov from November 12, 2024 to November 2, 2026; 39 have an industry sponsor and 137 are recruiting or about to. The newest, NCT07909460, was posted on November 2, 2026: Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis (University College, London).

The request: Every new Glioma clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

176New trials
39Industry sponsored
137Recruiting or not yet
November 2, 2026Latest posted

Newest trials

The newest 100 of 176, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 2, 2026	NCT07909460	Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis	University College, London	Observational	Not yet recruiting	Epilepsy, Glioma	56		clinicaltrials.gov
October 22, 2026	NCT07890038	The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant Tumors	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Observational	Active not recruiting	Nasopharyngeal Cancers, Lung Cancer (NSCLC), Esophageal Cancer, Glioma	50	China	clinicaltrials.gov
October 22, 2026	NCT07888647	IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas	German Cancer Research Center	Phase 2	Not yet recruiting	Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4	216	Germany	clinicaltrials.gov
October 9, 2026	NCT07867886	An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM	Boston Scientific Corporation	Not applicable	Not yet recruiting	Recurrent Glioblastoma	30	France, Germany, Netherlands, Spain	clinicaltrials.gov
October 5, 2026	NCT07859059	Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma	University of Nebraska	Phase 1/2	Not yet recruiting	High Grade Glioma, Glioblastoma, Gliosarcoma	41	United States	clinicaltrials.gov
September 22, 2026	NCT07832734	Metabolomics and Transcriptomics of Low- and High-Grade Gliomas	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio	Observational	Recruiting	IDH Wildtype Glioblastoma, IDH Mutant Lower-Grade Gliomas	220	Italy	clinicaltrials.gov
September 21, 2026	NCT07832123	Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study	University of Zurich	Phase 2	Not yet recruiting	Glioma : Oligodendroglioma or Astrocytoma	20	Switzerland	clinicaltrials.gov
September 18, 2026	NCT07826949	A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.	Nicholas Butowski	Phase 1	Not yet recruiting	Recurrent High-Grade Gliomas, Brain Neoplasm, Glioma	6	United States	clinicaltrials.gov
September 15, 2026	NCT07821112	Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®	University of California, Irvine	Phase 2	Not yet recruiting	Glioma, Glioblastoma, GBM, Glioma, Malignant, Astrocytoma, Oligodendroglioma, Elderly Glioblastoma, Elderly GBM	20	United States	clinicaltrials.gov
September 11, 2026	NCT07814872	A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment	Harvard Medical School (HMS and HSDM)	Observational	Not yet recruiting	Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic...	30,000	United States	clinicaltrials.gov
September 10, 2026	NCT07813741	Susceptibility-Weighted Imaging in Preoperative Grading of Cerebral Gliomas	Assiut University	Observational	Not yet recruiting	Glioma, Brain Neoplasms, Cerebral Glioma	90		clinicaltrials.gov
September 10, 2026	NCT07813377	Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of...	Fundacion Clinic per a la Recerca Biomédica	Observational	Recruiting	Glial Tumors, Thrombosis, Pulmonary Embolism (Diagnosis)	100	Spain	clinicaltrials.gov
August 27, 2026	NCT07791264	FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma	City of Hope Medical Center	Phase 1	Not yet recruiting	Glioblastoma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Malignant Glioma	24	United States	clinicaltrials.gov
August 26, 2026	NCT07788677	Tarlatamab Treatment Before and After Surgery in Surgically Resectable Recurrent High-grade Glioma: a Window of Opportunity Study...	Vall d'Hebron Institute of Oncology	Phase 1	Not yet recruiting	High-Grade Glioma (HGG)	10	Spain	clinicaltrials.gov
August 25, 2026	NCT07784985	A Study of NST-628 in Recurrent Grade 4 Glioma	Nader Sanai	Early phase 1	Not yet recruiting	Glioma, Recurrent High Grade, Grade 4 Malignant Glioma	12	United States	clinicaltrials.gov
August 24, 2026	NCT07781852	Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer	Lumina Pharmaceuticals Inc	Early phase 1	Not yet recruiting	Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)...	40	United States	clinicaltrials.gov
August 21, 2026	NCT07778979	Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas	University of Alabama at Birmingham	Early phase 1	Not yet recruiting	Glioma	20	United States	clinicaltrials.gov
August 10, 2026	NCT07754734	STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation	Dongguan People's Hospital	Phase 2	Not yet recruiting	Glioma, Glioblastoma (GBM), MGMT-Methylated Glioblastoma	138		clinicaltrials.gov
August 7, 2026	NCT07751744	Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal...	Jubilant Therapeutics Inc.	Phase 1/2	Not yet recruiting	Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG), Glioblastoma (GBM)	113		clinicaltrials.gov
August 6, 2026	NCT07750457	Proton vs. Photon Radiotherapy for Patients With WHO Grade 2-3 Glioma	University Hospital, Essen	Not applicable	Recruiting	Glioma	80	Germany	clinicaltrials.gov
July 29, 2026	NCT07733674	Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma...	Radiomedix, Inc.	Phase 1	Recruiting	Glioblastoma Multiforme (GBM), Pancreatic Ductal Adenocarcinoma (PDAC)	20	United States	clinicaltrials.gov
July 28, 2026	NCT07731555	Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological...	Patrick Morris	Not applicable	Recruiting	Glioblastoma	100	Ireland	clinicaltrials.gov
July 24, 2026	NCT07725640	Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade...	Batea Oncology	Not applicable	Not yet recruiting	Glioma, High-Grade Glioma (HGG), Surgical Resection	15	Spain	clinicaltrials.gov
July 21, 2026	NCT07717827	Connectome-guided Onco-functional Resection With Tractography-Extended Neuronavigation in Brain Tumor Surgery	ARNAS Civico Di Cristina Benfratelli Hospital	Observational	Recruiting	Brain (Nervous System) Cancers, Glioma, Brain Metastasases, Brain Connectivity	400	Italy	clinicaltrials.gov
July 17, 2026	NCT07710690	A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or...	Neuregen Therapeutics Co., Ltd.	Phase 1	Recruiting	HGG, High Grade Glioma (III or IV), High Grade Glioma	24	China	clinicaltrials.gov
July 16, 2026	NCT07707973	Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma	Tianjin First Central Hospital	Phase 2	Not yet recruiting	Glioma, Malignant	50		clinicaltrials.gov
July 14, 2026	NCT07703761	AI-driven Processing and Analysis of Glioma Imaging Data	Università degli Studi di Trento	Observational	Recruiting	Glioma, Glioma (Diagnosis)	700	Italy	clinicaltrials.gov
July 14, 2026	NCT07703605	AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors	Huashan Hospital	Observational	Not yet recruiting	Pediatric Brain Tumors, Glioma, Medulloblastoma, Ependymoma, Craniopharyngioma, Choroid Plexus Tumors	1,400		clinicaltrials.gov
July 14, 2026	NCT07703436	Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive...	Nuvation Bio Inc.	Phase 2	Recruiting	Grade 2 IDH1-mutant Glioma, Grade 3 IDH1-mutant Glioma, Glioma, IDH1-mutant Glioma, Oligodendroglioma...	40	United States	clinicaltrials.gov
July 13, 2026	NCT07699172	EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors	Bo Wang	Not applicable	Not yet recruiting	Glioma, Brain Neoplasm, Brain Tumor Adult	10	China	clinicaltrials.gov
July 13, 2026	NCT07698457	Clinical Benefit of 18F-FET in Glioma.	Primo Biotechnology Co., Ltd	Phase 3	Not yet recruiting	Glioma, 18F-Fluoroethyl-l-tyrosine	36	Taiwan	clinicaltrials.gov
July 7, 2026	NCT07687277	3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma Surgery	Lanzhou University Second Hospital	Observational	Active not recruiting	Glioma, Brain Neoplasms	75	China	clinicaltrials.gov
July 1, 2026	NCT07678684	A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma	HighField Biopharmaceuticals Corporation	Phase 2	Recruiting	Glioma, Adult	30	China	clinicaltrials.gov
June 30, 2026	NCT07675070	Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors	NanoAlvand	Observational	Recruiting	Brain Tumor, Grade III Glioma, Grade IV Glioma	100	Iran	clinicaltrials.gov
June 29, 2026	NCT07673705	GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma	Deep Learning Institute of Radiological Sciences	Observational	Completed	Glioma, Glioma (Diagnosis), Oligodendroglioma, 1p19q Codeletion, IDH-mutant Glioma (Oligodendroglioma, Astrocytoma)	1,372	India	clinicaltrials.gov
June 29, 2026	NCT07673692	GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma	Deep Learning Institute of Radiological Sciences	Observational	Completed	Glioma, Glioma (Diagnosis), Glioblastom WHO Grade 4, IDH Wildtype Glioblastoma	1,372	India	clinicaltrials.gov
June 29, 2026	NCT07673679	GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4	Deep Learning Institute of Radiological Sciences	Observational	Completed	Glioma, Glioma (Diagnosis), Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 4	1,372	India	clinicaltrials.gov
June 29, 2026	NCT07673666	GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)	Deep Learning Institute of Radiological Sciences	Observational	Completed	Glioma, Glioma (Diagnosis), Astrocytoma, Astrocytoma of Brain, Astrocytoma, Grade II, Astrocytoma, IDH-Mutant, Grade 2...	1,372	India	clinicaltrials.gov
June 24, 2026	NCT07664254	GliomaAI-MG: MRI-Based Detection of Molecular Glioblastoma	Deep Learning Institute of Radiological Sciences	Observational	Completed	Glioma, Glioma (Diagnosis), Glioblastom WHO Grade 4	1,372	India	clinicaltrials.gov
June 24, 2026	NCT07664176	NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors	Children's National Research Institute	Phase 1	Recruiting	Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas, Medulloblastoma Recurrent, Ependymoma...	30	United States	clinicaltrials.gov
June 16, 2026	NCT07650994	Movie-Watching Functional MRI for Mapping Brain Function in Neurosurgical Patients	Brigham and Women's Hospital	Not applicable	Not yet recruiting	Glioma, Brain Tumor Adult	90	United States	clinicaltrials.gov
June 12, 2026	NCT07644312	Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG	Nationwide Children's Hospital	Phase 2	Not yet recruiting	High Grade Glioma, Diffuse Intrinsic Pontine Glioma, WHO Grade 3 Glioma, WHO Grade 4 Glioma, Replication Repair...	12		clinicaltrials.gov
June 10, 2026	NCT07639970	Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors	Hua Pang	Early phase 1	Not yet recruiting	Breast Cancer, Head and Neck Cancer (H&N), Pancreatic Cancer, Glioma	20		clinicaltrials.gov
June 9, 2026	NCT07635173	SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas	Shenzhen Zhenxing Medical Technology Co., Ltd	Phase 1	Completed	Glioma, Glioblastomas (GBM), High Grade Gliomas	35	China	clinicaltrials.gov
June 8, 2026	NCT07631338	Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies	Hospital Italiano de Buenos Aires	Observational	Recruiting	Low-grade Glioma	40	Argentina	clinicaltrials.gov
June 5, 2026	NCT07629089	VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations	Megan Mantica	Phase 1	Not yet recruiting	Recurrent Glioma, IDH-mutant Gliomas	36	United States	clinicaltrials.gov
June 5, 2026	NCT07628647	Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being	University of Colorado, Denver	Not applicable	Recruiting	Brain Cancer	64	United States	clinicaltrials.gov
June 5, 2026	NCT07628634	Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors	University of California, Irvine	Early phase 1	Recruiting	Adenocarcinoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Ductal Carcinoma...	25	United States	clinicaltrials.gov
June 1, 2026	NCT07616726	Exploration and Characterization Ofintratumoral Electrophysiological Heterogeneity in Gliomas Using Magnetoencephalography	Hospices Civils de Lyon	Not applicable	Not yet recruiting	Patients Diagnosed With a Malignant Glioma	60	France	clinicaltrials.gov
May 29, 2026	NCT07612917	Brain Connectivity Changes in Glioma Patients During Treatment	Johannes Kepler University of Linz	Observational	Recruiting	Glioma (Any Grade) in the Brain, Gliomas, Malignant, fMRI Research, Neurocognitive Function	20	Austria	clinicaltrials.gov
May 27, 2026	NCT07609472	FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma	FluoGuide A/S	Phase 2	Not yet recruiting	High-Grade Glioma (WHO III-IV)	76	United States	clinicaltrials.gov
May 27, 2026	NCT07608003	Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:	Xiangya Hospital of Central South University	Observational	Recruiting	Gliomas Harboring IDH1 and/or IDH2 Mutations, Glioma Glioblastoma Multiforme, Glioma of Brainstem, Glioma, Diffuse...	500	China	clinicaltrials.gov
May 20, 2026	NCT07599371	A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of...	The First Affiliated Hospital of Zhengzhou University	Phase 1/2	Recruiting	Relapsed/Refractory Glioma	29	China	clinicaltrials.gov
May 5, 2026	NCT07567469	A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma...	Regeneron Pharmaceuticals	Phase 1/2	Not yet recruiting	High-Grade Glioma (HGG), Posterior Fossa-A Ependymoma	120		clinicaltrials.gov
May 5, 2026	NCT07567196	PET-Guided Resection in High-Grade Gliomas	Universita degli Studi di Genova	Observational	Recruiting	Glioma Glioblastoma Multiforme, Glioma, High Grade, Glioma Surgery, Positron-Emission Tomography(PET)	100	Italy	clinicaltrials.gov
April 28, 2026	NCT07553520	Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients	UNC Lineberger Comprehensive Cancer Center	Not applicable	Withdrawn	Glioblastoma Multiforme, Recurrent Glioma	0	United States	clinicaltrials.gov
April 24, 2026	NCT07551336	Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma	Beijing Biotech	Phase 1	Recruiting	Malignant Glioma, High-Grade Gliomas, Glioblastoma, Recurrent High-Grade Gliomas, Recurrent Glioblastoma	36	China	clinicaltrials.gov
April 23, 2026	NCT07547163	Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	Observational	Recruiting	Glioma, Glioma of Brain, Low Grade Glioma of Brain, Low Grade Gliomas, IDH Mutation	90	Italy	clinicaltrials.gov
April 21, 2026	NCT07542158	Ultralow Dose PET Imaging of 18F-FDOPA	Akiva Mintz	Phase 2	Enrolling by invitation	Heathy Volunteer, Parkinsonian Syndromes, Neuroendocrine (NE) Tumors, Gliomas	200	United States	clinicaltrials.gov
April 21, 2026	NCT07541781	Sitagliptin in Recurrent/Progressive Grade 4 Glioma	Kailin Yang, MD, PhD	Phase 1	Recruiting	Glioma, Glioblastoma, Recurrent Glioma, Recurrent Glioblastoma, Grade 4 Malignant Glioma of Brain (Disorder)	45	United States	clinicaltrials.gov
April 20, 2026	NCT07539441	A Study of Mirdametinib in People With Central Nervous System Tumors	Memorial Sloan Kettering Cancer Center	Phase 1/2	Recruiting	Central Nervous System Tumors, Glioma	26	United States	clinicaltrials.gov
April 15, 2026	NCT07532031	APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas	IRCCS Ospedale San Raffaele	Observational	Not yet recruiting	High-Grade Glioma, Glioblastoma, Brain Tumor Adult	20		clinicaltrials.gov
April 13, 2026	NCT07521657	Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma	University of Alabama at Birmingham	Phase 2	Not yet recruiting	Neurofibromatosis 1 (NF1)	55	United States	clinicaltrials.gov
March 30, 2026	NCT07499141	Use of Fluorescence in Gliomas	Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria	Observational	Completed	High Grade Glioma, Glioblastoma, Brain Neoplasms	41	Italy	clinicaltrials.gov
March 23, 2026	NCT07488780	Language Network Prehab Via fMRI Neurofeedback	Yale University	Not applicable	Recruiting	Glioma, Glioma Surgery	4	United States	clinicaltrials.gov
March 23, 2026	NCT07488754	Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)	Medical University of Warsaw	Not applicable	Recruiting	Glioblastoma, High-Grade Glioma (WHO III-IV), Glioblastoma (GBM)	35	Poland	clinicaltrials.gov
March 20, 2026	NCT07486713	Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies	Rigel Pharmaceuticals	Phase 4	Recruiting	AML (Acute Myeloid Leukemia), Glioma, Cholangiocarcinoma, Solid Tumor Malignancies	16	United States	clinicaltrials.gov
March 19, 2026	NCT07481721	IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma	Ming Yang	Phase 1	Not yet recruiting	Recurrent Malignant Glioma	24	China	clinicaltrials.gov
March 18, 2026	NCT07480941	Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma	Beijing Biotech	Phase 1	Recruiting	Glioblastoma, High-grade Glioma, Malignant Glioma, Recurrent Glioblastoma, Recurrent High-grade Glioma	36	China	clinicaltrials.gov
March 16, 2026	NCT07475390	99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging	Tomsk National Research Medical Center of the Russian Academy of Sciences	Not applicable	Active not recruiting	Glioma (Any Grade) in the Brain	40	Russia	clinicaltrials.gov
March 16, 2026	NCT07472790	A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma	Beijing Bio-Targeting Therapeutics Technology Co., Ltd	Phase 1	Not yet recruiting	High-grade Glioma	15	China	clinicaltrials.gov
March 13, 2026	NCT07471100	Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated...	Azienda Sanitaria dell'Alto Adige	Not applicable	Not yet recruiting	Brain Tumor Adult, Glioma, Glioma, High Grade	63		clinicaltrials.gov
March 13, 2026	NCT07469735	Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma	Huashan Hospital	Not applicable	Not yet recruiting	Glioma, Diffuse Glioma, Recurrent Gliomas	10	China	clinicaltrials.gov
March 12, 2026	NCT07468136	Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas	Mayo Clinic	Phase 1/2	Recruiting	Anaplastic Oligodendroglioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Diffuse Astrocytoma...	33	United States	clinicaltrials.gov
March 12, 2026	NCT07465796	A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma	Coherence Neuro Australia Pty Limited	Not applicable	Recruiting	Glioma, Tumor, Electrocorticography, Brain	10	Australia	clinicaltrials.gov
March 11, 2026	NCT07464925	A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma	Tetragon Biosciences Ltd	Phase 1	Recruiting	Glioblastoma Multiforme of Brain, Glioma, Glioblastoma	30	United States	clinicaltrials.gov
March 10, 2026	NCT07462507	Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1	Washington University School of Medicine	Phase 2	Recruiting	Central Nervous System Cancer, Brain Metastases	104	United States	clinicaltrials.gov
March 9, 2026	NCT07457307	Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac	NYU Langone Health	Phase 1	Not yet recruiting	High-grade Glioma	20	United States	clinicaltrials.gov
March 6, 2026	NCT07455045	A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	High Grade Glioma (III or IV), Diffuse Midline Glioma (DMG), Glioblastoma (GBM)	40	China	clinicaltrials.gov
March 5, 2026	NCT07450872	Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors	The Children's Hospital of Zhejiang University School of Medicine	Observational	Recruiting	Cancer, Glioma, Leukemia (Both ALL and AML)	600	China	clinicaltrials.gov
March 4, 2026	NCT07448480	Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas	Blokhin's Russian Cancer Research Center	Observational	Active not recruiting	Recurrent Malignant Glioma, Glioblastoma, Anaplastic Astrocytoma, Pleomorphic Xanthoastrocytoma	1,000	Russia	clinicaltrials.gov
March 3, 2026	NCT07447531	T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas	John M. Buatti	Not applicable	Recruiting	Malignant Glioma	15	United States	clinicaltrials.gov
February 27, 2026	NCT07440290	DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF...	Cancer Research UK	Phase 2/3	Recruiting	Haematological Malignancy, Malignant Neoplasm, Lymphoproliferative Disorders, Neoplasms by Histologic Type, Neoplasms...	30	United Kingdom	clinicaltrials.gov
February 27, 2026	NCT07439302	Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electronic Patient-reported Outcome...	Assistance Publique - Hôpitaux de Paris	Not applicable	Not yet recruiting	Oncology, Glioma	80	France	clinicaltrials.gov
February 27, 2026	NCT07439172	Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.	Cooper Norcross Health	Phase 2	Recruiting	High Grade Gliomas, Glioblastoma, Astrocytoma, Oligodendroglioma	70	United States	clinicaltrials.gov
February 27, 2026	NCT07438860	Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG	Tiffany Hodges	Phase 1	Not yet recruiting	Malignant Brain Tumors, Glioma	12	United States	clinicaltrials.gov
February 20, 2026	NCT07424092	Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors	Clinica Universidad de Navarra, Universidad de Navarra	Phase 2	Recruiting	High Grade Glioma, Ependymoma, Embryonal Tumor of Brain, Recurrence, Refractory, Pediatric, Young Adult	39	Netherlands, Spain	clinicaltrials.gov
February 18, 2026	NCT07416838	Quality of Life and Cognitive Functioning in Patients With Glial Tumors	Institute of Oncology Ljubljana	Not applicable	Completed	Glial Tumors	90	Slovenia	clinicaltrials.gov
February 18, 2026	NCT07416188	Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 1/2	Recruiting	Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Relapsed Cancer, Recurrent Tumor...	40	United States	clinicaltrials.gov
February 17, 2026	NCT07413796	Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted...	Medical University of Warsaw	Not applicable	Recruiting	Brain Tumor Adult, Brain Tumor Benign, Meningioma, Glioma, Glioblastoma	382	Poland	clinicaltrials.gov
February 17, 2026	NCT07411690	Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors	Medical University of Warsaw	Observational	Recruiting	Brain Tumor Adult, Brain Tumor Benign, CerebroSpinal Fluid (CSF) Leak, Craniotomy, Glioblastoma, Glioma, Meningioma	200	Poland	clinicaltrials.gov
February 12, 2026	NCT07405372	Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Observational	Recruiting	Glioma	10	China	clinicaltrials.gov
February 5, 2026	NCT07389278	Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)	Sabine Mueller, MD, PhD	Phase 1/2	Not yet recruiting	Glioblastoma, High-Grade Glioma (WHO III-IV), High-grade Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse...	97	United States	clinicaltrials.gov
January 30, 2026	NCT07379463	Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases	Tianjin Medical University	Observational	Recruiting	Amino-Acid Transport Disorder, Primary Hyperparathyroidism, Glioma	500	China	clinicaltrials.gov
January 29, 2026	NCT07376304	Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AI	Hospital del Rio Hortega	Phase 3	Not yet recruiting	Brain Tumor Adult	100		clinicaltrials.gov
January 29, 2026	NCT07374692	Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors	National Cancer Institute (NCI)	Observational	Completed	Recurrent CNS Tumors, Brain Cancer, Gliomas, IDH-wildtype Gliomas, IDH-mutant Gliomas, Rare CNS Tumor	4	United States	clinicaltrials.gov
January 26, 2026	NCT07366892	Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in...	Leica Microsystems (Schweiz) AG	Observational	Recruiting	Suspected Grade III and IV Gliomas Requiring Surgical Intervention, Neurosurgical Procedure, Glioma, Glioblastoma (GBM)	37	Portugal, Switzerland	clinicaltrials.gov
January 15, 2026	NCT07343492	fMRI Reveal Functional Preservation in Glioma Peritumoral Edema	West China Hospital	Observational	Completed	Glioma	44	China	clinicaltrials.gov
January 15, 2026	NCT07342699	Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases	West China Hospital	Observational	Completed	Gliomas	450	China	clinicaltrials.gov
January 14, 2026	NCT07338539	BIO-SHORT: Hypofractionated RT for Poor-Prognosis GBM	Tata Memorial Centre	Not applicable	Recruiting	Glioma	108	India	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Deep Learning Institute of Radiological Sciences	5	June 29, 2026
Mayo Clinic	4	March 12, 2026
NYU Langone Health	4	March 9, 2026
Tata Memorial Centre	4	January 14, 2026
Nationwide Children's Hospital	3	June 12, 2026
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	3	April 23, 2026
Medical University of Warsaw	3	March 23, 2026
West China Hospital	3	January 15, 2026
University of Zurich	2	September 21, 2026
University of California, Irvine	2	September 15, 2026
University of Alabama at Birmingham	2	August 21, 2026
Huashan Hospital	2	July 14, 2026
University of Colorado, Denver	2	June 5, 2026
Beijing Biotech	2	April 24, 2026
Memorial Sloan Kettering Cancer Center	2	April 20, 2026
Beijing Bio-Targeting Therapeutics Technology Co., Ltd	2	March 16, 2026
Cancer Research UK	2	February 27, 2026
Leica Microsystems (Schweiz) AG	2	January 26, 2026
Second Affiliated Hospital, Zhejiang University, School of Medicine	2	December 29, 2025
Telix Pharmaceuticals (Innovations) Pty Limited	2	November 20, 2025

By phase

Phase	New trials	Latest
Observational	50	November 2, 2026
Not applicable	36	October 9, 2026
Phase 1	32	September 18, 2026
Phase 2	25	October 22, 2026
Phase 1/2	15	October 5, 2026
Early phase 1	11	August 25, 2026
Phase 3	4	July 13, 2026
Phase 2/3	2	February 27, 2026
Phase 4	1	March 20, 2026

By country

Country	New trials	Latest
United States	57	October 5, 2026
China	38	October 22, 2026
Italy	10	September 22, 2026
Germany	9	October 22, 2026
India	9	June 29, 2026
France	5	October 9, 2026
Netherlands	5	October 9, 2026
Spain	5	October 9, 2026
Switzerland	4	September 21, 2026
Austria	3	May 29, 2026
Poland	3	March 23, 2026
Australia	3	March 12, 2026
Iran	2	June 30, 2026
Russia	2	March 16, 2026
United Kingdom	2	February 27, 2026
Canada	2	September 17, 2025
Finland	2	December 18, 2024
Ireland	1	July 28, 2026
Taiwan	1	July 13, 2026
Argentina	1	June 8, 2026
Slovenia	1	February 18, 2026
Portugal	1	January 26, 2026
Greece	1	July 22, 2025
New Zealand	1	February 21, 2025
Belgium	1	January 28, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.